Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2016 09:30 ET | Source: Vapogenix, Inc.

Vapogenix Secures $8.2 Million in Series C Funding to Advance Innovative Therapy for Wound Pain

HOUSTON, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Vapogenix, Inc., a clinical-stage company developing a topical, non-opioid medicine for localized pain, has raised $8.2 million to advance the development...